28 NOVEMBER 2007
RESULTS OF 2007 ANNUAL GENERAL MEETING 
Adelaide, Australia, 28 November 2007 - Ellex Medical Lasers Limited (ASX:ELX), a global leader in the design and manufacture of ophthalmic laser and ultrasound systems, is pleased to announce the results of resolutions put to the 2007 Annual General Meeting.
Resolution 2a: To elect Mr Victor Previn, who retires by rotation as a Director
| |
For
|
Against
|
Open
|
| Results of Proxy Votes |
15,989,870
|
14,200
|
820,977
|
Result: Approved
Resolution 2a: To elect Professor John Marshall as a Director
| |
For
|
Against
|
Open
|
| Results of Proxy Votes |
15,989,475
|
8,375
|
822,217
|
Result: Approved
Resolution 2b: To elect Mr Kevin McGuinness as a Director
| |
For
|
Against
|
Open
|
| Results of Proxy Votes |
15,712,810
|
285,000
|
822,217
|
Result: Approved
Resolution 3: To ratify the Previous issue of Ordinary Shares in accordance with Listing Rule 7.4
| |
For
|
Against
|
Open
|
| Results of Proxy Votes |
13,181,626
|
52,870
|
822,217
|
Result: Approved
Resolution 4: To adopt the Remuneration Report as set out in the Directors Report and Annual Report for the year to June 2007
| |
For
|
Against
|
Open
|
| Results of Proxy Votes |
15,802,816
|
106,090
|
822,217
|
Result: Approved
About Ellex
Ellex Medical Lasers Limited (ASX:ELX) designs, manufactures and markets a complete line of lasers and diagnostic ultrasound systems used by ophthalmologists to diagnose and treat eye diseases. With more than 12,000 systems delivered to the market, Ellex has evolved since 1985 from a manufacturing company of primarily OEM products, to direct marketing of its own branded products through subsidiaries in the United States, Japan and Australia, and a network of distribution partners in more than 100 countries. In December 2006 Ellex acquired Innovative Imaging, a leading provider of diagnostic ultrasound devices for ophthalmology, initiating the expansion of its product line beyond lasers. Ellex maintains a strong emphasis on intellectual property and research into new and better treatments to manage and treat the leading causes of blindness.
|
